BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1269 related articles for article (PubMed ID: 28069703)

  • 1. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside diphosphate kinase B regulates angiogenesis through modulation of vascular endothelial growth factor receptor type 2 and endothelial adherens junction proteins.
    Feng Y; Gross S; Wolf NM; Butenschön VM; Qiu Y; Devraj K; Liebner S; Kroll J; Skolnik EY; Hammes HP; Wieland T
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2292-300. PubMed ID: 25147336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation.
    Most P; Lerchenmüller C; Rengo G; Mahlmann A; Ritterhoff J; Rohde D; Goodman C; Busch CJ; Laube F; Heissenberg J; Pleger ST; Weiss N; Katus HA; Koch WJ; Peppel K
    Circ Res; 2013 Jan; 112(1):66-78. PubMed ID: 23048072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoglycin knockdown promotes vascular smooth muscle cell proliferation and migration in aortic dissection via the VEGF/VEGFR2 axis.
    Wang Z; Zhuang X; Chen B; Wei M
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
    Hsieh MJ; Liu HT; Wang CN; Huang HY; Lin Y; Ko YS; Wang JS; Chang VH; Pang JS
    J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.
    Jiang L; Yin M; Wei X; Liu J; Wang X; Niu C; Kang X; Xu J; Zhou Z; Sun S; Wang X; Zheng X; Duan S; Yao K; Qian R; Sun N; Chen A; Wang R; Zhang J; Chen S; Meng D
    Circ Res; 2015 Jul; 117(4):364-375. PubMed ID: 26123998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
    Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
    Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
    Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2.
    Park C; Lee TJ; Bhang SH; Liu F; Nakamura R; Oladipupo SS; Pitha-Rowe I; Capoccia B; Choi HS; Kim TM; Urao N; Ushio-Fukai M; Lee DJ; Miyoshi H; Kim BS; Lim DS; Apte RS; Ornitz DM; Choi K
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):86-96. PubMed ID: 26586661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice.
    Okadome J; Matsumoto T; Yoshiya K; Matsuda D; Tamada K; Onimaru M; Nakano K; Egashira K; Yonemitsu Y; Maehara Y
    J Vasc Surg; 2018 Aug; 68(2):576-586.e1. PubMed ID: 28974341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis.
    Luo Y; Xu Z; Wan T; He Y; Jones D; Zhang H; Min W
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1307-14. PubMed ID: 20395596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells.
    Lanahan AA; Lech D; Dubrac A; Zhang J; Zhuang ZW; Eichmann A; Simons M
    Circulation; 2014 Sep; 130(11):902-9. PubMed ID: 24982127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
    Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.
    Di Bartolo BA; Cartland SP; Prado-Lourenco L; Griffith TS; Gentile C; Ravindran J; Azahri NS; Thai T; Yeung AW; Thomas SR; Kavurma MM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26572549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.